Corporate Tech Investors

Pathology Asia

Pathology Asia is a corporate VC investing group that makes strategic investments in technologies that align with its strategic interests.

Venture Investor Overview

Venture Investor
Pathology Asia
Status
InActive
Investor Type
Corporate
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Christopher Ting
Title
Chief Executive Officer
Mailing Address
80 Raffles Pl. UOB Plaza 15-01
Singapore, 048624
Singapore
Phone
Undisclosed
Website
Email Address
Not Recorded

Background Information

Overview
Pathology Asia Holdings is operator of a holding company with businesses in the pathology sector.
Profile
Pathology Asia LinkedIn Company Profile
Social Media
Pathology Asia Company Twitter Account
Company News
Pathology Asia News
Facebook
Pathology Asia on Facebook
YouTube
Pathology Asia on YouTube
Last Transaction
5/13/2021

Transaction History

Our records indicate that Pathology Asia invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
5/13/2021
$70,000,000

 


Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
Christopher Ting
  Christopher Ting LinkedIn Profile  Christopher Ting Twitter Account  Christopher Ting News  Christopher Ting on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Pathology Asia has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more corporate investors:

Pasona Tech | Patoma

 

Share this article

 


About Our Corporate Tech Investing Database

This corporate tech investment data comes via a partnership with VentureDeal.com, a leading provider of corporate tech investing transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary